Ishita Drugs & Industries Ltd.
BSE: 524400 | Sector: Health care |
NSE: N.A. | ISIN Code: INE806D01016 |
BSE 09:53 | 27 Jan | 50.80 |
-1.70 (-3.24%) |
OPEN
53.55 |
HIGH
53.55 |
LOW
50.80 |
NSE 05:30 | 01 Jan | Ishita Drugs & Industries Ltd |
OPEN | 53.55 |
PREVIOUS CLOSE | 52.50 |
VOLUME | 335 |
52-Week high | 79.55 |
52-Week low | 36.10 |
P/E | 18.68 |
Mkt Cap.(Rs cr) | 15 |
Buy Price | 51.00 |
Buy Qty | 20.00 |
Sell Price | 53.00 |
Sell Qty | 10.00 |
Ishita Drugs & Industries Ltd. (ISHITADRUGS) - Peer Group
COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
Oxygenta Pharma | 29.95 | -4.77 | 42.53 | 6.06 | -2.34 | 0.00 | - |
Sanjiv.Parant. | 36.45 | 3.26 | 36.45 | 8.33 | 0.77 | 5.67 | 6.43 |
Shukra Pharma. | 226.90 | 5.00 | 35.62 | 3.72 | 0.08 | 7.02 | 32.32 |
Decipher Labs | 27.40 | 0.92 | 27.67 | 12.12 | 1.19 | 0.26 | 105.38 |
Concord Drugs | 31.50 | 0.64 | 27.53 | 13.72 | 0.18 | 0.94 | 33.51 |
Zenith Health | 5.06 | 0.40 | 27.17 | 2.59 | 0.07 | 0.02 | 253.00 |
Panjon | 16.90 | 4.32 | 26.20 | 1.98 | 0.05 | 0.00 | - |
Ortin Labs. | 23.35 | -1.89 | 18.98 | 13.16 | 0.44 | 0.00 | - |
Phaarmasia | 26.80 | -0.19 | 18.30 | 6.67 | -0.29 | 0.00 | - |
Earum Pharmaceu. | 2.62 | 0.00 | 16.17 | 7.11 | 0.04 | 0.10 | 26.20 |
Ishita Drugs | 50.80 | -3.24 | 15.19 | 2.84 | 0.12 | 2.72 | 18.68 |
Guj. Terce Labs. | 19.00 | -0.78 | 14.10 | 10.13 | 0.45 | 0.00 | - |
Parmax Pharma | 35.20 | 0.28 | 13.16 | 2.13 | -0.70 | 0.00 | - |
Guj. Inject(Ker) | 7.50 | -2.60 | 3.68 | 0.03 | 0.03 | 0.13 | 57.69 |
Quick Links for Ishita Drugs & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices